Description

Hetero Tenofovir/Lamivudine 300mg/300mg is a fixed-dose combination tablet used as PrEP (Pre-Exposure Prophylaxis) to reduce the risk of HIV infection in individuals at substantial risk. This combination delivers Tenofovir Disoproxil Fumarate 300mg and Lamivudine 300mg in one convenient daily tablet.

Key Benefits

• Reliable PrEP option for reducing HIV infection risk.
• Once-daily protection, easy to integrate into routine.
• Two NRTIs in one tablet for enhanced preventive action.
• Quality-assured product manufactured by Hetero Healthcare.

How It Works

Tenofovir and Lamivudine block HIV’s ability to replicate if exposure occurs. When taken consistently, they help prevent the virus from establishing infection.

Who Can Use It

• Individuals at high or ongoing risk of HIV exposure, including those with HIV-positive partners, multiple partners, or inconsistent condom use.
• PrEP must be initiated only after confirming an HIV-negative status.
• It is not recommended for people with significant kidney disease unless medically reviewed.

How to Use

• Take 1 tablet once daily, preferably at the same time each day.
• Must be paired with regular HIV testing and follow-up with a healthcare provider.
• Daily adherence is essential for maximum protection.

Safety Information

• Routine kidney function monitoring is recommended.
• Possible side effects: mild nausea, headache, loss of appetite, or abdominal discomfort.
• Do not use this for PrEP if you are already HIV positive.

Pack Content

Box of 30 tablets.

For more information about it, please click here.